Wildcat Capital Management, LLC
Wildcat Capital Management, LLC reported 5 US-listed holdings worth $174.4 million in its 13F for the quarter ended 30 September 2026, filed 28 October 2026. Its largest: Frontier Group Holdings Inc. (96.1%), Allogene Therapeutics Inc. (2.7%) and Netskope Inc. (0.7%). Against the quarter before, it opened 3 positions, added to 0, trimmed 0 and sold out of 1.
The 5 largest of its 5 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q2 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned +25.1% over the 8 quarters to 30 September 2026, against +32.9% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 30 June 2026; a change under 0.1% of a position counts as held
Opened 3
- Netskope Inc.$1.1 million
- Figure Technology Solutions, Inc. FIGR$845,276
- Procore Technologies, Inc. PCOR$199,174
Sold out of 1
- Chime Financial, Inc. CHYM$488,940 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Frontier Group Holdings Inc. ULCC | 28.1M | $167.5 million | 96.07% | no change |
| Allogene Therapeutics Inc. ALLO | 2.9M | $4.7 million | 2.68% | no change |
| Netskope Inc. | 65.2K | $1.1 million | 0.65% | new |
| Figure Technology Solutions, Inc. FIGR | 29.3K | $845,276 | 0.48% | new |
| Procore Technologies, Inc. PCOR | 3.9K | $199,174 | 0.11% | new |